NCT06744738

Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Thuraya Safaa Ibrahim · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A parallel-group, cluster-randomized, controlled trial designed to evaluate if hemodialysis patients benefit from BCT. The study includes two groups: usual care and pharmacist-led intervention groups.

Conditions

• Hemodialysis
• End Stage Renal Disease Requiring Hemodialysis

Interventions

Type	Name	Description
BEHAVIORAL	Pharmacist led behavioral change technique	The intervention was developed based on the behavior change technique taxonomy (v1). This intervention was designed to improve adherence to all therapeutic aspects of hemodialysis patients, including the dialysis program, medications, diet, and fluids. Additionally, the effect of the pharmacist intervention on physiological indices (serum potassium, total calcium, phosphate, IDWG, and hemoglobin) was examined. The program was explicitly created for implementation in an actual setting, ensuring that the time allocation for participants and facilitators (the party responsible for conducting the PL-BCT) remained reasonable in most contexts. The BCT components were developed after the identification and coding of the BCTs from previous interventional studies that contain behavioral components and result in positive effects on one or more hemodialysis patients' adherence domains toward their therapeutic regimen (dialysis program, medications, diet, and fluid).

Timeline

• Start date: 2024-02-02
• Primary completion: 2024-06-25
• Completion: 2024-06-25
• First posted: 2024-12-20
• Last updated: 2024-12-20

Locations

1 site across 1 country: Iraq